Sylvamo Posts $85M Continuing-Ops Profit as $342M Europe Impairment Drives $4.98 Net Loss
SLVM sits 23% above its 52-week low of $30.4.
Summary
Sylvamo's Q3 shows $85 million of continuing-operations income and $128 million of adjusted EBITDA, but a $342 million noncash Europe impairment drives a reported $4.98 per-share net loss. Europe is now booked as discontinued operations ahead of the proposed sale.
Key Events · Earnings and Guidance · SLVM
-
Q3 Continuing Operations Earn $85M
Net income from continuing operations was $85 million ($2.13 per diluted share) on $645 million of net sales, a 13% margin.
-
$342M Europe Impairment Drives Net Loss
Discontinued operations lost $284 million, primarily a $342 million noncash impairment of the Europe segment, producing a reported net loss of $199 million ($4.98 per diluted share).
-
Adjusted EBITDA Nearly Doubles Sequentially
Adjusted EBITDA rose to $128 million (20% margin) from $66 million in Q2 2026, helped by $38 million lower planned maintenance outage costs and $25 million of price/mix improvement.
-
Europe Recast as Discontinued Operations
The Europe business, including mills in Saillat, France and Nymolla, Sweden, is now reported as discontinued operations with prior periods recast, following the put option agreement with Midas Atlantic Partners.
Analysis · SLVM · Manufacturing
The headline net loss is an accounting artifact, not an operating deterioration: continuing operations earned $85 million ($2.13 per diluted share), while discontinued Europe operations booked a $342 million noncash impairment that pushed the reported net loss to $199 million. Adjusted EBITDA of $128 million nearly doubled from $66 million in Q2 as planned maintenance outages fell $38 million and price/mix added $25 million. What matters is the shape of the company after the Europe sale — a more focused Latin America and North America paper business generating $128 million of quarterly EBITDA, with $93 million of cash and $861 million of long-term debt on the balance sheet.
How filings like this one have moved
In the 30 days to Nov 6, 2026, 35.1% of the 2636 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, SLVM was trading at $37.47 on NYSE in the Manufacturing sector, with a market capitalization of approximately $1.3B. The 52-week trading range was $30.40 to $56.80. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.